Cargando…
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022
Background: Respiratory recurrent papillomatosis (RRP) is a fatal disease with no known cure. In severe RRP cases, systemic bevacizumab (SB) could be used as adjuvant therapy. Objective: This study aims to determine the extent and type of evidence in relation to the clinical outcomes of RRP after SB...
Autores principales: | Torres-Canchala, Laura, Cleves-Luna, Daniela, Arias-Valderrama, Oriana, Candelo, Estephania, Guerra, María Angelica, Pachajoa, Harry, Olaya, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856545/ https://www.ncbi.nlm.nih.gov/pubmed/36670605 http://dx.doi.org/10.3390/children10010054 |
Ejemplares similares
-
Microduplication of Xp22.31 and MECP2 Pathogenic Variant in a Girl with Rett Syndrome: A Case Report
por: Candelo, Estephania, et al.
Publicado: (2019) -
Hearing Loss in Patients With Morquio Syndrome: Protocol for a Scoping Review
por: Diaz-Ordoñez, Lorena, et al.
Publicado: (2022) -
A Novel Intronic KMT2D Variant as a Cause of Kabuki Syndrome: A Case Report
por: Aristizábal, Erica, et al.
Publicado: (2021) -
A novel de novo TBX5 mutation in a patient with Holt-Oram syndrome
por: Ríos-Serna, Lady J, et al.
Publicado: (2018) -
Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia()
por: López-Quintero, William, et al.
Publicado: (2021)